Rezo Therapeutics is a Google Cloud-native oncology company that uses AI to map protein-protein interactions — the complex biological networks that drive cancer — in pursuit of small-molecule drugs for targets historically considered "undruggable." By leveraging Gemini models, GPUs, TPUs, and Gemini Enterprise Agent Platform, Rezo can now generate hundreds of thousands of structurally resolved protein complexes in just weeks, cutting target discovery time in half.
No quantified outcome stated in the source.
Source: Google Cloud
Verification: describes AI agent taking actions/multi-step work
HEINEKEN used Azure AI Foundry to create a multi-agent platform that enables employees to access data and information across the company in their native language. With the help of …
Rede Américas , a Latin American hospital network with 25 hospitals and 400 partner health insurance companies, became an early adopter of Gemini Enterprise Agent Platform in the r…
The Eon AI Agent empowers cloud infrastructure teams to streamline data protection operations. It connects Google Cloud accounts, triggers resource discovery, monitors protected re…
Genentech’s gRED Research Agent, built with Claude on Amazon Bedrock Agents, autonomously multi-steps scientific queries across PubMed and internal repositories, expected to automa…
Genspark AI Agent turns multi-step work into finished outputs with one prompt by combining search, web interaction, content generation, and media creation. It helps users execute r…
Merck is reshaping research and development through a Gemini Enterprise-powered "agentic engine" that condenses weeks of regulatory filing work into a single afternoon.
One email a week with newly verified agent use cases and their outcomes.
Placeholder form: not connected yet.